Western blot analysis of 15 paired patient samples further confirmed the down-regulation of NR1D2 in tumor tissues relative to adjacent normal tissues, with consistent GAPDH expression validating experimental reliability (P < 0.001, Figures 6B, D). Here, NR1D2 is linked to neoplasm.